|
|
Correlation between Serum Interleukin-6 Level and Myocardial Damage in Paediatric Mycoplasma Pneumonia |
XU Li, ZHANG Rui, SHI Qingkang, et al |
No.901 Hospital,Joint Logistics Support Force of the Chinese People's Liberation Army, Anhui Hefei 230009, China |
|
|
Abstract Objective: To analyze the correlation between serum Interleukin-6 (IL-6) level and myocardial damage (MD) in paediatric mycoplasma pneumonia (MPP). Methods: One hundred and thirty-eight children with MPP treated in our hospital from June 2019 to June 2021 were enrolled for the research and divided into MD group and non-MD group according to the disease process. The gender, age, blood leukocyte (WBC), procalcitonin (PCT), C-reactive protein (CRP), creatine kinase-MB isoenzyme (CK-MB), cardiac troponin I (cTnI), IL-6 levels and hospitalization time were compared between the two groups. The area under the curve (AUC) of receiver operating characteristic (ROC) curve was performed to evaluate the diagnostic value of these indexes for MD. Pearson correlation was used to analyze the relationship between serum IL-6 level and hospitalization time. Results: Myocardial damage occurred in 33 of 138 children, with an incidence of 23.9%. The serum levels of CRP, PCT, CK-MB, cTnI, IL-6 and hospitalization time in MD group were significantly higher than those in non-MD group (P<0.05). There were no significant differences in gender, age and WBC between two groups (P>0.05). The results of ROC curve showed that IL-6, CK-MB and cTnI had high diagnostic value for myocardial damage (AUC > 0.9) while CRP and PCT had certain diagnostic value (AUC 0.7 ~ 0.9), but age and WBC had no obvious diagnostic value (AUC < 0.7). Pearson correlation analysis showed that the serum IL-6 level of all children was significantly positively correlated with the length of hospital stay (r = 0.328, P = 0.001 <0.05). Conclusion: Serum level of IL-6 has a potential diagnostic value for the occurrence of myocardial damage in children with MPP, and it is related to the length of hospital stay, which is worthy of clinical reference.
|
|
|
|
|
[1] 崔莹莹,王琳,王玲玲.肺炎支原体肺炎患儿外周血CCL2、CCL4、CXCL8、CXCL9水平与心肌损伤的关系[J].解放军医药杂志,2020,32(3):48-53. [2] 王国玉,曲忠慧,李伟,等.探讨高流量湿化氧疗对老年肺炎患者临床疗效及炎症因子IL-8IL-6的影响[J].河北医学,2021,27(8):1321-1325. [3] 王东杰.急性心肌梗死患者IL-6、TNF-α、INF-γ、VEGF、Fg、hs-CRP水平变化及其与介入治疗关系的研究[J].国际检验医学杂志,2019,40(6):750-753. [4] 胡亚美,江载芳.诸福棠实用儿科学[M].第8版.北京:人民卫生出版化,2015.1280-1282. [5] 冯媛元,陈梅.肺炎支原体肺炎合并心肌损伤患儿血清E-选择素及可溶性细胞间黏附分子-1的变化及其意义[J].现代医药卫生,2019,35(22):3440-3443. [6] 张俊哲,敖苗.血清CXCL9水平与支原体肺炎患儿发生心肌损伤的相关性[J].医药论坛杂志,2021,42(16):103-105. [7] 李智琼,孙承谋,朱玲娜,等.MP-IgM、YKL-40、APOC1和IL-6在儿童支原体肺炎治疗及预后中的意义[J].标记免疫分析与临床,2019,26(4):576-579,619. [8] 滕嘉硕,李梦思,罗远良,等.心脏成纤维细胞释放的IL-6在阿霉素致SD乳鼠心肌细胞损伤中的作用研究[J].中国病理生理杂志,2021,37(6):1004-1010. [9] 尚白雪,丁家望,汪心安,等.急性心肌梗死患者血清IL-6水平与冠状动脉狭窄程度的相关性分析[J].巴楚医学,2019,2(3):6-9. [10] 王旭敏,章恒,熊英,等.IL-6、IL-27与ST段抬高型心肌梗死患者冠状动脉介入治疗预后的关系[J].中国动脉硬化杂志,2019,27(3):221-226. |
|
|
|